Erythroid Response in Patients with Non-Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Long-Term Data from the BEYOND Trial
Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Ali T. Taher, Vip Viprakasit, Maria Domenica Domenica Cappellini, Antonio Piga, John B. Porter, Thomas D. Coates, Khaled M. Musallam, Gian Luca Forni, Jeevan K. Shetty, Marija Bosilkovska Weisskopf, Richard Wei, Wen-Ling Kuo, Antonis Kattamis
Institutions: American University of Beirut Medical Center, Mahidol University, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Turin, University College London, Children's Hospital Los Angeles, Keck Hospital of USC, Ente Ospedaliero Ospedali Galliera, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), National and Kapodistrian University of Athens
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310113770